FFR

FFR is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets ("RWA") and the deployment of Embodied Artificial Intelligence ("EAI") in commercial environments. FFR aims to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems. In September 2025, the company closed a $41 million PIPE financing. In November 2025, it rebranded from Qualigen Therapeutics to AIxCrypto Holdings, Inc. (Nasdaq: AIXC). Following this, the company operated across three business lines: the BesTrade DeAI Agent platform, the C10 digital asset treasury and portfolio management tools, and the RWA Embodied AI (EAI) ecosystem. In February 2026, FFR's board decided to concentrate on the RWA + Embodied AI (EAI) ecosystem. As a result, the company has discontinued development of the BesTrade platform and the C10 portfolio management tools. These products were early-stage proofs of concept and did not align with the company's revised focus on enterprise and institutional infrastructure regarding scale, regulatory profile, or margin characteristics. FFR does not anticipate material impairment charges beyond what has been previously disclosed due to this discontinuation. Separately, the company is evaluating strategic options for its therapeutics programs, previously under the Qualigen brand.